The Annual Broegelmann Lectures
The Broegelmann lectures are a series of annually held lectures since 1997 about current hot topics in the field of immunology. The lectures feature nationally and internationally invited speakers and are arranged by the Research group Immunology and Rheumatology, NSI Bergen and the Bergen Research School in Inflammation.
Previously held lectures
The 23rd Broegelmann Lectures (2022), Molecular basis for sexual dimorphism in autoimmune disease by Professor Marie Wahren Herlenius, MD, PhD, Division of Rheumatology at Karolinska Institutet, Stockholm.
The 22nd Broegelmann Lectures (2021), Role of Tim-3 in regulating anti-tumor immunity, by Professor Vijay Kumar Kuchroo, DVM, PhD.
The 21st Broegelmann Lectures (2019), Lymphocyte cytotoxicity in health and disease by Professor Yenan Bryceson, Karolinska Instituttet and University of Bergen.
Towards personalized therapy for inflammatory diseases by Professor Silke Appel, University of Bergen.
Single cell immune profiling in personalized therapy: early response evaluation in myeloid leukemia using mass cytometry by Professor Bjørn-Tore Gjertsen, University of Bergen and Haukeland University Hospital.
The 20th Broegelmann Lecture (2018), Pathogenic memory cells - a roadblock to tolerance induction in chronic inflammatory diseases by Professor Andreas Radbruch Dr. rer. nat. Scientific Director of The German Rheumatism Research Centre, Professor of Rheumatology at the Charité Medical Centre and Humboldt University of Berlin, Germany.
The 19th Broegelmann Lecture (2016), T Cell Immunoregulatory Signal Networks and Tumor Immune Evasion Mechanisms by Professor Kjetil Taskén MD, PhD Director of the Centre for Molecular Medicine Norway Biotechnology Centre, University of Oslo.
The 18th Broegelmann Lecture (2014), Insights on the molecular specificity and biological function of NK cells by Professor Hans-Gustaf Ljunggren MD, PhD, Dean of Research, Karolinska Institutet, Director, Center for Infectious Medicine Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
The 17th Broegelmann Lecture (2013), Oxidative control of immunity and inflammation by Professor Rikard Holmdahl M.D., Ph.D. Karolinska Institutet, Stockholm, Sweden.
The 16th Broegelmann Lecture (2012), Proteases of periodontal pathogens as a weapon of choice in intelligent guerilla warfare against host immune system by Professor Jan Potempa Ph.D., D.Sc. Jagiellonian University and University of Louisville.
The 15th Broegelmann Lecture (2011), New insights into the etiology of rheumatoid arthritis – is prevention possible?, by Professor Lars Klareskog MD, med. dr. Karolinska Institute.
The 14th Broegelmann Lecture (2010), Virus and lymphocytes - a personal experience of the origin and development of the HIV/AIDS pandemic by Professor Stig S. Frøland MD, dr. med. Oslo University Hospital, Oslo.
The 13th Broegelmann Lecture (2009), "A Human Protein Atlas” by Professor Mathias Uhlén, Dept. of Proteomics, School of Biotechnology AlbaNova University Center, Stockholm.
The 12th Broegelmann Lecture (2008), "Atherosclerosis – an immune-mediated disease” Professor Göran K. Hansson, MD, PhD, Center for Molecular Medicine Karolinska Institute, Stockholm.
The 10th Broegelmann lecture (2006), ”B cells and natural autoantibodies” John F. Kearney, Professor of Microbiology, The University of Alabama at Birmingham, AL, USA.
The 9th Broegelmann lecture (2005), The gut-joint axis: clinically relevant? Professor Per Brandtzaeg LIIPAT, Institute of Pathology, The National Hospital, Norway.
The 8th Broegelmann lecture (2004), Gene transfer as a tool for understanding and managing organ-directed autoimmunity by Bruce J. Baum.
The 7th Broegelmann lecture (2003), Aquaporin water channels - from atomic structure to clinical medicine by Peter C. Agre, M.D. Professor of Biological Chemistry and Medicine, Johns Hopkins University School of Medicine, Baltimore.
The 6th Broegelmann lecture (2002), Mucosal vaccination: Routes of immunization and antigen delivery systems to stimulate immune response and tolerance by Jiri Metstecky.
The 5th Broegelmann lecture (2001), B cell development by Fritz Melcher.
The 4th Broegelmann lecture (2000), Defining the Pathogenicity of Autoantibodies in SLE by Dr. Morris Reichlin, M.D.Vice President of Research and Scientific Director Oklahoma Medical Research Foundation, Oklahoma, USA.
The 3rd Broegelmann lecture (1999), The Genes of Systemic Autoimmunity by Professor Argyrios N. Theofilopoulos, M.D.
The 2nd Broegelmann lecture (1998), “New therapeutic directions in the treatment of rheumatic disease” by Professor. William J. Koopman, The University of Alabama at Birmingham,USA.
The 1st Broegelmann lecture (1997), Control of autoantibody production in health and disease by Professor Jacob B. Natvig, Oslo, Norway